A Phase 1 Safety Study Of Sbp-101, A Polyamine Metabolic Inhibitor, For Pancreatic Ductal Adenocarcinoma (Pda).
JOURNAL OF CLINICAL ONCOLOGY(2018)
摘要
e16231Background: SBP-101 (diethyl dihydroxyhomospermine), a polyamine (PA) analogue of spermine, inhibited growth in 6 human PDA cell lines and 3 murine xenograft tumor models. A Phase 1 dose esca...
更多查看译文
关键词
polyamine metabolic inhibitor,pancreatic ductal adenocarcinoma
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要